Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force.
Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, Borasio GD, Bradley WG, Bromberg MB, Brooks BR, Kasarskis EJ, Munsat TL, Oppenheimer EA. Miller RG, et al. Among authors: sufit r. Neurology. 1999 Apr 22;52(7):1311-23. doi: 10.1212/wnl.52.7.1311. Neurology. 1999. PMID: 10227612 No abstract available.
Promoting excellence in end-of-life care in ALS.
Mitsumoto H, Bromberg M, Johnston W, Tandan R, Byock I, Lyon M, Miller RG, Appel SH, Benditt J, Bernat JL, Borasio GD, Carver AC, Clawson L, Del Bene ML, Kasarskis EJ, LeGrand SB, Mandler R, McCarthy J, Munsat T, Newman D, Sufit RL, Versenyi A. Mitsumoto H, et al. Among authors: sufit rl. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Sep;6(3):145-54. doi: 10.1080/14660820510028647. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005. PMID: 16183556 Review.
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence-based review).
Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, Borasio GD, Bradley WG, Bromberg MB, Brooks BR, Kasarskis EJ, Munsat TL, Oppenheimer EA. Miller RG, et al. Among authors: sufit r. Muscle Nerve. 1999 Aug;22(8):1104-18. doi: 10.1002/(sici)1097-4598(199908)22:8<1104::aid-mus15>3.0.co;2-2. Muscle Nerve. 1999. PMID: 10417794 No abstract available.
The impact of the approval of riluzole.
Sufit R, Newman D. Sufit R, et al. Neurology. 1996 Oct;47(4 Suppl 2):S117. doi: 10.1212/wnl.47.4_suppl_2.117s. Neurology. 1996. PMID: 8858065 No abstract available.
Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.
Miller RG, Bouchard JP, Duquette P, Eisen A, Gelinas D, Harati Y, Munsat TL, Powe L, Rothstein J, Salzman P, Sufit RL. Miller RG, et al. Among authors: sufit rl. Neurology. 1996 Oct;47(4 Suppl 2):S86-90; discussion S90-2. doi: 10.1212/wnl.47.4_suppl_2.86s. Neurology. 1996. PMID: 8858057 Clinical Trial.
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group. Kaufmann P, et al. Among authors: sufit r. Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743. Ann Neurol. 2009. PMID: 19743457 Free PMC article. Clinical Trial.
Web-based data management for a phase II clinical trial in ALS.
Buchsbaum R, Kaufmann P, Barsdorf AI, Arbing R, Montes J, Thompson JL; QALS Study Group. Buchsbaum R, et al. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):374-7. doi: 10.3109/17482960802378998. Amyotroph Lateral Scler. 2009. PMID: 19922127 Free PMC article.
111 results